Frankfurt - Delayed Quote EUR
KALA BIO, Inc. (27F0.F)
2.6940
+0.0820
+(3.14%)
As of 9:24:30 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 27F0.F | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 8/19/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/17/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/2/2024 |
Related Tickers
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
ACOG Alpha Cognition Inc. Common Stock
4.9200
+7.89%
LPTX Leap Therapeutics, Inc.
0.3950
+2.33%
CRIS Curis, Inc.
1.5000
+4.90%
MREO Mereo BioPharma Group plc
2.5600
+2.40%
SWTX SpringWorks Therapeutics, Inc.
41.21
+1.75%
APVO Aptevo Therapeutics Inc.
0.7400
+6.72%
IOVA Iovance Biotherapeutics, Inc.
3.1900
-0.62%
VKTX Viking Therapeutics, Inc.
25.79
+1.22%